Interestingly, MET-H1094Y was the most commonly identified MET TKD mutation at baseline and the most frequently occurring subtype mutation mutually exclusive to known oncogenic drivers (Fig. 2), implying that it could play an oncogenic role in NSCLC. This evidence concerns the gene MET and non-small cell lung carcinoma.